Geratherm Medical AG
Geratherm Medical AG: 2020 – Best financial year so far (preliminary business figures)
Geratherm Medical AG / Key word(s): Annual Results Publication of insider information in accordance with Article 17 MAR, 2020 – Best financial year so far (preliminary business figures)
– Revenues EUR 27.5 million +38.4% – EBITDA 4,347 kEUR + 84.7% – EBITDA-Margin 15.8% + 32.8% – Operating profit (EBIT) 3,039 kEUR +189.7% – result from ordinary operations 2,719 kEUR +161.9% – Earnings per share 41 cents (previous year: 11 cents) – Return on equity 10.3% – Equity ratio 55.4% – Cash and securities EUR 10.3 million – Proposed dividend: 40 cents per share – Still strong international demand for Geratherm medical products Geratal, March 23, 2021: Geratherm Medical AG (ISIN: DE0005495626) had a very good performance, especially in the last 9 months of 2020 financial year. Sales increased by +38.4%. The result from ordinary business operations clearly increased to more than double. All product segments had a strong increase in sales. Healthcare Diagnostic EUR 18.4 million, +40.1%; Respiratory EUR 4.8 million, +14.2%; Medical warming systems EUR 2.4 million, +184.2%; Cardio/Stroke 1.9 million EUR, +11.0%. The detailed Annual Report 2020 will be published on April 28, 2021. Geratherm Medical AG Short company profil: Contact: Dr. Gert Frank
23-March-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Geratherm Medical AG |
Fahrenheitstraße 1 | |
99331 Geratal | |
Germany | |
Phone: | +49 (0)36205 98-0 |
Fax: | +49 (0)36205 98-1 15 |
E-mail: | info@geratherm.com |
Internet: | www.geratherm.com |
ISIN: | DE0005495626 |
WKN: | 549562 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1177537 |
End of Announcement | DGAP News Service |